Design, synthesis, molecular modeling, and ADMET studies of some pyrazoline derivatives as shikimate kinase inhibitors
- 137 Downloads
A series of pyrazoline derivatives were synthesized and their structures have been characterized by IR, 1H NMR, 13C NMR, mass spectral and elemental analysis. The novel compounds were designed as Mycobacterium tuberculosis shikimate kinase (MtSK) inhibitors based on docking studies using Sybyl-X 2.0 software. In silico ADMET predictions revealed that all compounds had minimal toxic effects and had good absorption as well as solubility characteristics. Thus these compounds may serve as potential lead compound for developing new anti-tubercular drug.Among the tested compounds 4c, 5b, and 6a exhibited promising antitubercular activity. Additional, some compounds were also evaluated for their cytotoxic activity against EAC cell lines using the tryphan blue exclusion method.
KeywordsPyrazolines Antitubercular activity Mycobacterium tuberculosis Shikimate Kinase
The authors are thankful to Nitte University, Mangalore for the financial support. Also acknowledge NGSM Institute of Pharmaceutical Sciences, Mangalore for providing the facilities. We also thank Maratha Mandal Dental College, Belguam for providing facilities for antitubercular activity tests. Director, SAIF, Indian Institute of Science, Bangalore, India, and Director, CSRI, Lucknow, India for NMR and mass spectral analysis.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no competing interests.
- Agarwal NA, Soni PA (2005) Reaction of 2’-hydroxy-5’-acetamido chalcones with dimethyl sulfoxide-iodine, pyridine-mercuric(II) acetate and triethanolamine. Indian J Chem 44B:2601–2603Google Scholar
- Bandodkar BS, Schmitt S (2007) Pyrazolonederivates, processes for preparing them, pharmaceutical compositions containing them, and their use as inhibitors of the MtSK (Mycobacterium tuberculosisshikimate kinase) enzyme. Patent: WO/ 2007/020426 A1Google Scholar
- Bandodkar SB, Schmitt S (2010) Pyrazoline derivative forthe treatment of tuberculosis.United States Patent Application Publication(ASTRAZENECA R&D BOSTON) Pub. No:0179161A1Google Scholar
- Cohen NC (1996) Guidebook on Molecular Modelling in Drug Design. Academic Press, San DiegoGoogle Scholar
- Holla BS, Mahalinga M, Poojary B, Ashok M, Akberali PM (2006) Synthesis of Pyrazolines Promoted by Amberlyst-15 Catalyst. Indian J Chem 45B:568–571Google Scholar
- Joshi SD, Dixit SR, Kirankumar MN, Aminabhavi TM, Raju KVSN, Narayan R et al. (2016) Synthesis, antimycobacterial screening and ligand-based molecular docking studies on novel pyrrole derivatives bearing pyrazoline, isoxazole and phenyl thiourea moieties. Eur J Med Chem 107:133–152CrossRefPubMedGoogle Scholar
- Mistry BD, Desai KR, Patel JA, Patel NI (2012) Conventional and microwave assisted synthesis of pyrazole derivatives and screening of their antibacterial and antifungal activities. Ind J Chem 51:746–751Google Scholar
- Nitin NA, Soni PA (2007) Synthesis of pyrazole and isoxazole in triethanolamine medium. Ind J Chem 46B:532–534Google Scholar
- Shandala MY, Hamdy AM (2008) Synthesis of Some New Substituted 1,3,5-Triaryl Pyrazolines. Nat J Chem 30:338–342Google Scholar
- Soni N, Pande K, Kalsi R, Gupta TK, Parmar SS, Barthwal JP (1987) Inhibition of rat brain monoamineoxidase and succinic dehydrogenase by anticonvulsant pyrazolines. Res Commun Cement Pathol Pharm 56:129–132Google Scholar
- Sreejayan N, Rao MNA (1996) Free radical scavenging activity by curcuminoids. Drug Res 46:169–171Google Scholar
- Swaminathan S (2002) Basic concepts in the treatment of tuberculosis. Indian J Pediatr 69:44–49Google Scholar
- Tripos International. (2012) Sybyl-X 2.0, Tripos International, St. Louis, MO, USAGoogle Scholar
- Wermuth CG (1996) The Practice of Medicinal Chemistry. Academic Press, San DiegoGoogle Scholar